Uso de posaconazol en niños: experiencia en un hospital pediátrico de alta complejidad

Rosanova, María T; Voto, Carla; Mussini, María S; Sarkis, Claudia; Gómez, Sandra; Sberna, Norma; Carnovale, Susana; Caracciolo, Beatriz; Lede, Roberto.
Arch. argent. pediatr ; 116(3): 451-454, jun. 2018. tab
Artigo Espanhol | LILACS, BINACIS | ID: biblio-950025

Documentos relacionados

  1. A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication.
  2. A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections.
  3. Evaluation of target attainment of oral posaconazole suspension in immunocompromised children.
  4. Invasive bone and joint infections from the French Scedosporiosis/lomentosporiosis Observational Study (SOS) cohort: no mortality with long-term antifungal treatment and surgery.
  5. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
  6. Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism.
  7. Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients.
  8. Future Fungal Fighters in Dermatology: Novel Antifungal Drug Pipeline.
  9. Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?
  10. The Argentinian landscape of mycological diagnostic capacity and treatment accessibility.